| Biomarkers and therapeutic advances in glioblastoma multiforme |
26 |
| Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies |
17 |
| Strain-specific probiotic (microbial cell preparation) and omega-3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: a randomized controlled trial |
13 |
| PD-L1 expression associated with worse survival outcome in malignant pleural mesothelioma |
13 |
| Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic review |
13 |
| The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage ?-? colorectal cancer |
12 |
| Cancer multidisciplinary team meetings in practice: Results from a multi-institutional quantitative survey and implications for policy change |
11 |
| Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers |
10 |
| Primary thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta-analysis of randomized controlled trials (RCTs) |
10 |
| Clinical response to apatinib monotherapy in advanced non-small cell lung cancer |
9 |
| Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study |
9 |
| Increased exhausted CD8(+) T cells with programmed death- T-cell immunoglobulin and mucin-domain-containing-3 phenotype in patients with multiple myeloma |
9 |
| Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer |
8 |
| Treatment-related toxicities of immune checkpoint inhibitors in advanced cancers: A meta-analysis |
8 |
| Medical and non-medical expenditure for breast cancer diagnosis and treatment in China: amulticenter cross-sectional study |
8 |
| Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer |
7 |
| Epidemiology of head and neck cancer in Thailand |
7 |
| Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma |
7 |
| Efficacy, safety and predictive indicators of apatinib after multilines treatment in advanced nonsquamous nonsmall cell lung cancer: Apatinib treatment in nonsquamous NSCLC |
7 |
| Management of epidermal growth factor receptor tyrosine kinase inhibitor-related cutaneous and gastrointestinal toxicities |
6 |
| CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer |
6 |
| Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017 |
5 |
| Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma |
5 |
| Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities? |
5 |
| Downregulated miR- miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in Tcell acute lymphoblastic leukemia |
5 |
| Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets |
5 |
| FLT3-ITD positive acute myeloid leukemia: A retrospective analysis of the role of allogeneic transplant and allelic ratio in patient management |
5 |
| Downregulation of nicotinamide nucleotide transhydrogenase and its naturally occurring antisense RNA in gastric cancer |
5 |
| Ga-68-PSMA-PET/CT staging prior to definitive radiation treatment for prostate cancer |
5 |
| Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea |
5 |
| UGT1A1*6 and UGT1A1*28 polymorphisms are correlated with irinotecan-induced toxicity: A meta-analysis |
5 |
| Oncologist provision of smoking cessation support: A national survey of Australian medical and radiation oncologists |
4 |
| Observation of complete clinical response in rectal cancer after neoadjuvant chemoradiation: The Flinders experience |
4 |
| Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7cm |
4 |
| The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma |
4 |
| Clinical concepts for cabazitaxel in the management of metastatic castration-resistant prostate cancer |
4 |
| Genome-wide expression profiling and bioinformatics analysis of deregulated genes in human gastric cancer tissue after gastroscopy |
4 |
| Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis |
4 |
| The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia |
4 |
| Initial experience of sleeve lobectomy under complete video-assisted thoracic surgery |
4 |
| Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer |
4 |
| Implementation of the Australasian Teletrial Model: Lessons from practice |
4 |
| Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) |
4 |
| The c-Myc-regulated miR-17-92 cluster mediates ATRA-induced APL cell differentiation |
4 |
| The challenge of putting principles into practice: Resource tensions and real-world constraints in multidisciplinary oncology team meetings |
4 |
| Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma |
4 |
| Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma |
4 |
| Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy |
4 |
| Utilization of stereotactic ablative radiotherapy in oligometastatic & oligoprogressive skeletal metastases: Results and pattern of failure |
4 |
| Re-inventing the randomized controlled trial in medical oncology: The registry-based trial |
4 |
